Adermark L and Lovinger DM |
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step. |
2007 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:18077376
|
Béquet F et al. |
CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus. |
2007 |
Eur. J. Neurosci. |
pmid:18052990
|
Gokoh M et al. |
2-Arachidonoylglycerol enhances the phagocytosis of opsonized zymosan by HL-60 cells differentiated into macrophage-like cells. |
2007 |
Biol. Pharm. Bull. |
pmid:17603153
|
Degn M et al. |
Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. |
2007 |
J. Neurochem. |
pmid:17868306
|
Sugiura T |
[2-Arachidonoylglycerol: an endogenous cannabinoid receptor ligand]. |
2007 |
Seikagaku |
pmid:17763698
|
He F et al. |
Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor. |
2007 |
Mol. Pharmacol. |
pmid:17698952
|
Ho WS and Randall MD |
Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. |
2007 |
Br. J. Pharmacol. |
pmid:17245358
|
Guindon J et al. |
The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors. |
2007 |
Br. J. Pharmacol. |
pmid:17179944
|
Imming P |
Fatty pain cures. |
2007 |
Chem. Biol. |
pmid:18096498
|
King AR et al. |
URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. |
2007 |
Chem. Biol. |
pmid:18096504
|
Dainese E et al. |
Modulation of the endocannabinoid system by lipid rafts. |
2007 |
Curr. Med. Chem. |
pmid:17979719
|
Fan SF and Yazulla S |
Retrograde endocannabinoid inhibition of goldfish retinal cones is mediated by 2-arachidonoyl glycerol. |
2007 May-Jun |
Vis. Neurosci. |
pmid:17592669
|
Sakamoto Y et al. |
Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock. |
2007 Sep-Oct |
ASAIO J. |
pmid:17885340
|
Moreira FA et al. |
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. |
2008 |
Neuropharmacology |
pmid:17709120
|
Vellani V et al. |
Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. |
2008 |
Neuropharmacology |
pmid:18329052
|
Guindon J and Hohmann AG |
A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism. |
2008 |
Br. J. Pharmacol. |
pmid:18297102
|
Hu SS et al. |
Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. |
2008 |
Br. J. Pharmacol. |
pmid:18297109
|
Sheinin A et al. |
Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region. |
2008 |
J. Neurophysiol. |
pmid:18497350
|
Zhang J and Chen C |
Endocannabinoid 2-arachidonoylglycerol protects neurons by limiting COX-2 elevation. |
2008 |
J. Biol. Chem. |
pmid:18534982
|
Muccioli GG and Stella N |
An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. |
2008 |
Anal. Biochem. |
pmid:17981259
|